CONMED Corp — Director's Dealing 2023

Mar 3, 2023

SEC Form 4/A — Form 4/A

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2023-03-01

Reporting Person: Peterson Jaclyn (VP of Mfg. & Adv. Engineering)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-01	Common Stock	M	250	—	Acquired	829	Direct
2023-03-01	Common Stock	F	90	$96.16	Disposed	739	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-03-01	Rsus (restricted Stock Units)	$0	M	250	Disposed	2032-03-01	Common Stock (250)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.